Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
ERCC2 (Excision repair cross-complementation group 2)
i
Other names:
ERCC2, EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD, Excision repair cross-complementation group 2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2068
Related tests:
‹
Oncomine™ Comprehensive Assay v3M (2)
Labcorp® Plasma Complete™
Oncomine™ Comprehensive Assay v3M (2)
Labcorp® Plasma Complete™
›
Associations
(17)
News
Trials
VERI cancer hierarchy
Reset Filters
ERCC2 K751G
Osteosarcoma
ERCC2 K751G
Osteosarcoma
cisplatin
Resistant: C3 – Early Trials
cisplatin
Resistant
:
C3
cisplatin
Resistant: C3 – Early Trials
cisplatin
Resistant
:
C3
ERCC2 D312N
Osteosarcoma
ERCC2 D312N
Osteosarcoma
cisplatin
Resistant: C3 – Early Trials
cisplatin
Resistant
:
C3
cisplatin
Resistant: C3 – Early Trials
cisplatin
Resistant
:
C3
ERCC2 V242F
Urothelial Cancer
ERCC2 V242F
Urothelial Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
ERCC2 P463L
Urothelial Cancer
ERCC2 P463L
Urothelial Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
ERCC2 E606G
Urothelial Cancer
ERCC2 E606G
Urothelial Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
ERCC2 N238S
Urothelial Cancer
ERCC2 N238S
Urothelial Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
ERCC2 G665A
Urothelial Cancer
ERCC2 G665A
Urothelial Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
ERCC2 D609G
Urothelial Cancer
ERCC2 D609G
Urothelial Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
ERCC2 D609E
Urothelial Cancer
ERCC2 D609E
Urothelial Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
ERCC2 Y24C
Urothelial Cancer
ERCC2 Y24C
Urothelial Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
ERCC2 mutation
Bladder Cancer
ERCC2 mutation
Bladder Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
ERCC2 E606Q
Urothelial Cancer
ERCC2 E606Q
Urothelial Cancer
cisplatin
Sensitive: C4 – Case Studies
cisplatin
Sensitive
:
C4
cisplatin
Sensitive: C4 – Case Studies
cisplatin
Sensitive
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.